KCNN4 and Alzheimer disease: Recent studies demonstrated that the KCa3.1 channel is upregulated in post-mortem sections of AD patients, and in 5XFAD transgenic AD mice starting from three to four months of age, at the insurgence of Aβ amyloidosis and microglial activation.